Depressed cardiac myofilament function in human diabetes mellitus

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  Jweied, Eias E ^a   McKinney, Ronald D ^a   Walker, Lori A ^a   Brodsky, Irwin ^a   Geha, Alexander S ^a   Massad, Malek G ^a   Buttrick, Peter M ^a   De Tombe, Pieter P ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Heart failure; Myofilament function; Sarcomere; Skinned myocardium

Indexed keywords

CALCIUM ION;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLE; DISEASE ASSOCIATION; FEMALE; FORCE; FROZEN SECTION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HUMAN; HUMAN TISSUE; MALE; MYOFILAMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SARCOMERE;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MICROFILAMENTS; MIDDLE AGED; MUSCLE FIBERS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 28144458155     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00638.2005     Document Type: Article

References (44)

1. Ahmad FK, He Z, and King GL. Molecular targets of diabetic cardiovascular complications. Curr Drug Targets 6: 487-494, 2005.
2. 1-adrenoceptor down-regulation in aging and heart failure: implications for β-blocker use in older adults with heart failure. Eur J Heart Fail 5: 709-715, 2003.
3. 2+ sensitivity of skinned cardiac muscle contractility coincident with troponin T-band shifts in the diabetic rat. Circ Res 76: 600-606, 1995.
4. American Heart Association. Heart and stroke statistical update. JAMA 286: 1195-2000, 2002.
5. Anderson PA, Malouf NN, Oakeley AE, Pagani ED, and Allen PD. Troponin T isoform expression in the normal and failing human left ventricle: a correlation with myofibrillar ATPase activity. Basic Res Cardiol 87: 117-127, 1992.
6. Anderson PAW, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, and Kay BK. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 76: 681-686, 1995.
7. Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, and Allen PD. Troponin-T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res 69: 1226-1233, 1991.
8. Barbato JC, Huang QQ, Hossain MM, Bond M, and Jin JP. Proteolytic N-terminal truncation of cardiac troponin I enhances ventricular diastolic function. J Biol Chem 280: 6602-6609, 2005.
9. Biesiadecki BJ, Elder BD, Yu ZB, and Jin JP. Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals with high instances of dilated cardiomyopathy. J Biol Chem 277: 50275-50285, 2002.
10. Braunwald E, Seidman CE, and Sigwart U. Contemporary evaluation and management of hypertrophic cardiomyopathy. Circulation 106: 1312-1316, 2002.
11. Bristow M. Antiadrenergic therapy of chronic heart failure: surprises and new opportunities. Circulation 107: 1100-1102, 2003.
12. Burkart EM, Sumandea MP, Kobayashi T, Nili M, Martin AF, Homsher E, and Solaro RJ. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem 278: 11265-11272, 2003.
13. Colantonio DA, Van Eyk JE, and Przyklenk K. Stunned peri-infarct canine myocardium is characterized by degradation of troponin T, not troponin I. Cardiovasc Res 63: 217-225, 2004.
14. De Tombe PP. Altered contractile function in heart failure. Rev Cardiovasc Res 37: 367-380, 1998.
15. De Tombe PP and Solaro RJ. Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure. Ann Biomed Eng 28: 991-1001, 2000.
16. De Tombe PP and Stienen GJ. Protein kinase A does not alter economy of force maintenance in skinned rat cardiac trabeculae. Circ Res 76: 734-741, 1995.
17. Fan DS, Wannenburg T, and de Tombe PP. Decreased myocyte tension development and calcium responsiveness in rat right ventricular pressure overload. Circulation 95: 2312-2317, 1997.
18. Galderisi M, Anderson KM, Wilson PW, and Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68: 85-89, 1991.
19. 2+ sensitivity of force development in the presence of slow skeletal troponin I: insights into the role of troponin T isoforms in the fetal heart. J Biol Chem 279: 49579-49587, 2004.
20. Kobayashi T, Yang X, Walker LA, Van Breemen RB, and Solaro RJ. A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C. J Mol Cell Cardiol 38: 213-218, 2005.
21. Konhilas JP, Irving TC, Wolska BM, Jweied EE, Martin AF, Solaro RJ, and de Tombe PP. Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol 547: 951-961, 2003.
22. Malhotra A, Rang BP, Cheung S, Opawumi D, and Meggs LG. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin 1. Diabetes 50: 1918-1926, 2001.
23. Malhotra A, Lopez MC, and Nakouzi A. Troponin subunits contribute to altered myosin ATPase activity in diabetic cardiomyopathy. Mol Cell Biochem 151: 165-172, 1995.
24. Malhotra A, Reich D, Nakouzi A, Sanghi V, Geenen DL, and Buttrick PM. Experimental diabetes is associated with functional activation of protein kinase C-ε and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 81: 1027-1033, 1997.
25. McConnell BK, Moravec CS, Morano I, and Bond M. Troponin I phosphorylation in spontaneously hypertensive rat heart: effect of β-adrenergic stimulation. Am J Physiol Heart Circ Physiol 273: H1440-H1451, 1997.
26. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, and Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 286: 1195-1200, 2001.
27. Murphy AM, Kogler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, and Marban E. Transgenic mouse model of stunned myocardium. Science 287: 488-491, 2000.
28. Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, and Seidman CE. Sarcomere protein gene mutations in hypertrophie cardiomyopathy of the elderly. Circulation 105: 446-451, 2002.
29. 2+-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem 270: 25445-25454, 1995.
30. Noland TA Jr, Raynor RL, Jideama NM, Guo X, Kazanietz MG, Blumberg PM, Solaro RJ, and Kuo JF. Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. Biochemistry 35: 14923-14931, 1996.
31. Parmacek MS and Solaro RJ. Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis 47: 159-176, 2004.
32. Perez NG, Hashimoto K, McCune S, Altschuld RA, and Marban E. Origin of contractile dysfunction in heart failure: calcium cycling versus myofilaments. Circulation 99: 1077-1083, 1999.
33. Piccini JP, Klein L, Gheorghiade M, and Bonow RO. New insights into diastolic heart failure: role of diabetes mellitus. Am J Med 116, Suppl 5A: 64S-75S, 2004.
34. Pyle WG, Sumandea MP, Solaro RJ, and De Tombe PP. Troponin I serines 43/45 and regulation of cardiac myofilament function. Am J Physiol Heart Circ Physiol 283: H1215-H1224, 2002.
35. Saba Z, Nassar R, Ungerleider RM, Oakeley AE, and Anderson PA. Cardiac troponin T isoform expression correlates with pathophysiological descriptors in patients who underwent corrective surgery for congenital heart disease. Circulation 94: 472-476, 1996.
36. Solaro RJ. Modulation of cardiac myofilament activity by protein phosphorylation. In: Handbook of Physiology. The Cardiovascular System. The Heart. Bethesda, MD: Am Physiol Soc, 2002, sect. 2, vol. I, chapt. 7, p. 264-300.
37. Solaro RJ. Myosin and why hearts fail. Circulation 85: 1945-1947, 1992.
38. Solaro RJ. Protein Phosphorylation in Heart Muscle. Boca Raton, FL: CRC, 1986.
39. Sumandea MP, Burkart EM, Kobayashi T, De Tombe PP, and Solaro RJ. Molecular and integrated biology of thin filament protein phosphorylation in heart muscle. Ann NY Acad Sci 1015: 39-52, 2004.
40. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, and Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 278: 35135-35144, 2003.
41. Towbin JA and Solaro RJ. Genetics of dilated cardiomyopathy: more genes that kill. J Am Coll Cardiol 44: 2041-2043, 2004.
42. 2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 57: 37-47, 2003.
43. Wolff MR, Buck SH, Stoker SW, Greaser ML, and Mentzer RM. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered β-adrenergically mediated protein phosphorylation. J Clin Invest 98: 167-176, 1996.
44. Zakhary DR, Moravec CS, Stewart RW, and Bond M. Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation 99: 505-510, 1999.